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a b s t r a c t
Carotenoids and their derivatives are versatile isoprenoids involved in many varied actions, hence their
importance in the agri-food industry, nutrition, health and other ﬁelds. All carotenoids are derived from
the colorless carotenes phytoene and phytoﬂuene, which are oddities among carotenoids due to their
distinct chemical structure. They occur together with lycopene in tomato and other lycopene-containing
foods. Furthermore, they are also present in frequently consumed products like oranges and carrots,
among others. The intake of phytoene plus phytoﬂuene has been shown to be higher than that of
lycopene and other carotenoids in Luxembourg. This is likely to be common in other countries. However,
they are not included in food carotenoid databases, hence they have not been linked to health beneﬁts in
epidemiological studies. Interestingly, there are evidences in vitro, animal models and humans indicating
that they may provide health beneﬁts. In this sense, the study of these colorless carotenes in the context
of food science, nutrition and health should be further encouraged. In this work, we review much of the
existing knowledge concerning their chemical characteristics, physico-chemical properties, analysis,
distribution in foods, bioavailability and likely biological activities.
 2015 Elsevier Inc. All rights reserved.
Introduction
Phytoene (7,8,11,12,70,80,110,120-octahydro-w, w-carotene, PT1)
and phytoﬂuene (7,8,11,12,70,80-hexahydro-w, w-carotene, PTF)
were already studied in the 1940s, with a wealth of dedicated
investigations in the 1950s [1–7]. They can be considered as rarities
within the ‘‘Carotenoid Kingdom’’ as they are colorless. However,
they are key carotenoids because they are precursors of all the
others. This is why they have been extensively studied in investiga-
tions dealing with the biosynthesis of these compounds. Surpris-
ingly, they have been largely neglected as compared to other
carotenoids in other kinds of studies, despite they are known to
occur in widely consumed foods. Likewise they are among the pre-
dominant carotenoids in human plasma and tissues. In this work,
aspects like chemical features, properties, analysis, occurrence in
foods, bioavailability and likely biological activities of PT and PTF
are reviewed.
Chemical structure and physico-chemical properties
PT and PTF are linear hydrocarbons with molecular formulae
C40H64 (MW = 544 Da) and C40H62 (MW = 542 Da), respectively.
More speciﬁcally, they are alkenes with 9 and 10 double bonds,
respectively. In the case of PT, three of the double bonds are conju-
gated, whereas PTF has ﬁve conjugated double bonds (c.d.b.)
(Fig. 1) [8]. The system of alternating double and single bonds is
one of the main structural characteristics of carotenoids. This is
an electron-rich conjugated system in which the p-electrons are
delocalized and is considered the structural feature mainly related
to the light-absorbing properties, reactivity and shape of carote-
noids [9]. The system of c.d.b. in PT and PTF is clearly shorter com-
pared to other dietary carotenoids (for instance, lycopene, another
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linear carotene, contains 11 c.d.b.) (Fig. 2), so both PT and PTF are
expected to exhibit important differences in some physico-
chemical properties compared to other carotenoids.
Light absorbing properties
According to the data tabulated in reference books, PT absorbs
maximally at 286 nm and the spectrum also exhibit two shoulders
at 276 and 297 nm in petroleum ether, its ﬁne structure being low
(%III/II = 10). In the case of PTF, the kmax is 348 in petroleum ether.
The spectrum has sharp absorption bands (%III/II = 90) with other
absorption maxima at 331 and 367 nm [10,11]. The relationships
between the length and arrangement of the system of c.d.b. of
common dietary carotenoids on the color parameters of the CIELAB
uniform space is well understood. Although the color of
carotenoids is dependent on factors others than just their chemical
structure (like concentration and interaction with other molecules,
among others), it is considered that at least 7 c.d.b. are needed for a
carotenoid to exhibit color [12], hence PT and PTF are considered
colorless carotenoids. On the other hand PTF is known to ﬂuores-
cence at around 510 nm when it is excited with near-UV light
[13]. This property can be certainly used to enhance its detection
or for other analytical purposes.
Reactivity
In contrast to other carotenoids, there are not many speciﬁc
data relative to the susceptibility of PT and PTF to oxidation in
model systems. In a recent study, this was compared in PT, PTF
and LYC by in silico strategies and the ABTS radical cation decolor-
ation assay. The theoretical and experimental results were found to
agree well and indicated that, as it could be presumed from their
chemical structures, PT and PTF were not as effective antiradicals
as LYC. However, the comparison of the experimental TEAC with
those reported for other carotenoids by other authors indicated
that PT and PTF seem to be better scavengers of the ABTS radical
cation than it may be expected beforehand [14]. Interestingly,
and contrary to what it could be expected from its structure, PTF
is known to be very unstable in the presence of oxygen [8]. More
studies assessing the behavior of these carotenoids under different
oxidation conditions and by other approaches are warranted.
Shape
The study of the geometry of molecules as well as their size or
presence of functional groups is important to help understand
where they can ﬁt in structures or how they interact with other
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Fig. 1. Chemical structures of possible geometrical isomers of phytoene and
phytoﬂuene.
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molecules [9]. PT and PTF are, like LYC, linear carotenes that do not
contain rings in their structures [8]. The polyene chain of c.d.b.
confers rigidity to the carotenoid molecule. Since the number of
c.d.b. is much lower in PT and PTF than in LYC, they are expected
to adopt shapes very different relative to most carotenoids in
general and LYC in particular.
On the other hand, the differentiation between different
geometrical isomers of carotenoids (Fig. 1) is important as they
can exhibit important differences in shape and some properties.
This differences can in turn have an impact in their solubilization,
stability, absorption, metabolism and transport [9,15–17], and
therefore in their possible biological actions.
As far as PT and PTF are concerned, it is well-known that (15Z)-
phytoene is the predominant PT isomer in most carotenogenic
organisms [18,19]. (15Z)-Phytoﬂuene is also thought to be the
predominant isomer in many sources [8,19]. Several geometrical
isomers of PTF are known to occur in red tomatoes, although their
conclusive identiﬁcation remains obscure [20,21]. At least 3 geo-
metrical isomers of PT and 6 of PTF can be readily formed and
detected by using conventional stereomutation procedures and
routine analytical procedures [22]. Chemical and in silico evidences
indicate that certain Z-isomers of both phytoene and phytoﬂuene
could be thermodynamically favoured over the respective (all-E)-
isomers [23].
Biosynthesis
Carotenoids are biosynthesized by all photosynthetic organisms
as well as some non-photosynthetic bacteria and fungi. In any case,
the typical commited step of carotenoid biosynthesis is the con-
densation of two molecules of the C20 compound geranylgeranyl
pyrophosphate (GGPP) to form (15Z)-phytoene, the major PT iso-
mer in most carotenogenic organisms [18,19], as stated before.
This reaction is catalyzed by the enzyme phytoene synthase (PS),
which is a key regulatory enzyme in the pathway [24–27]. Phyto-
ene is therefore the precursor of all carotenoids. Phytoﬂuene is
formed by the action of phytoene desaturases, which insert one
double bond extending the system of conjugated double bonds
by two (Fig. 2). (15Z)-Phytoﬂuene is also thought to be the
predominant isomer in many sources [8,28]. The evolution of the
carotene desaturation reactions has been comprehensively
reviewed by Sandmann [29].
Fungi and some bacteria
The formation of phytoene from GGPP is catalyzed by a phyto-
ene synthase generally referred to as CRTB. The biosynthesis of
lycopene from phytoene is thought to be catalyzed by only one
desaturase enzyme, encoded by crtI (reviewed in [30,31]) (Fig. 2).
CRTI is found in fungi and some prokaryotes like heliobacteria,
green ﬁlamentous bacteria, purple photosynthetic bacteria and
other bacteria that biosynthesize carotenoids (with the exception
of green-sulfur bacteria and cyanobacteria) [32]. Rhodobacter cap-
sulatus was the bacteria species from where the crtI gene was ﬁrst
cloned [33,34]. Some years later, such gene was cloned from the
fungus Neurospora crassa [35]. There is evidence that the cyanobac-
teria Gloeobacter violaceus carries out the synthesis of lycopene like
non-photosynthetic bacteria (i.e. by means of CRTI). This is an
exception among oxygenic photosynthetic organisms. In this
regard, it is thought that, in ancestral cyanobacteria, the desatura-
tion of phytoene was initially catalyzed by CRTI, although this
protein was eventually replaced by CRTP and other desaturases,
which would be acquired later [32,36,37]. A strategy to produce
13C-labeled phytoene in Escherichia coli by using 13C-glucose as
carbon source has been recently described. In brief, carotenogenic
genes from Enterobacter agglomerans were inserted in E. coli, and
the function of the CRTI protein was modiﬁed by error-prone PCR
to obtain strains accumulating that carotenoid. The 13C-labeled
phytoene is expected to expand our knowledge about the fate of
this carotenoid in animals [38].
Oxygenic photosynthetic organisms
Currently it is generally accepted that the desaturation of phy-
toene (7,8,11,12,70,80,110,120-octahydro-w,w-carotene) to form suc-
cessively phytoﬂuene (7,8,11,12,70,80-hexahydro-w,w-carotene),
Fig. 2. Simpliﬁed scheme of steps catalyzed by carotene desaturases in carotenogenic organisms: (PDS: phytoene desaturase; ZDS: f-carotene desaturase; CRTI: desaturase
encoded by the crtI gene). ⁄Except cyanobacteria.
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f-carotene (7,8,70,80-tetrahydro-w,w-carotene), neurosporene (7,8-
dihydro-w,w-carotene) and ﬁnally lycopene (w,w-carotene) in
plants requires four steps. These are catalyzed by enzymes like
phytoene desaturase (PDS), f-carotene isomerase (ZISO), f-caro-
tene desaturase (ZDS) and carotenoid isomerase (CRTISO) (Fig. 2).
Light-mediated photoisomerization is also required at some steps
[27,39–43]. The bleaching compounds used to inhibit desaturases
in these organisms were found to not be effective in bacteria and
fungi. This observation added support to the hypothesis that the
carotene desaturation was markedly distinct between both groups
of organisms [29].
Cyanobacteria
The enzymes involved in the synthesis of phytoene and phytoﬂ-
uene in several cyanobacteria (like Synecocystis sp., Gloeobacter sp.
or Synechococcus sp., Chlorobaculum sp.) have been the subject of
several studies [36,44–47]. The desaturation of phytoene to
eventually form lycopene is accepted to need in most cases three
proteins, namely CrtP (a phytoene desaturase that catalyzes the
formation of f-carotene via phytoﬂuene), CrtQ (f-carotene desatur-
ase) and CrtH (cis-carotene isomerase) [32]. The ﬁrst phytoene
desaturase gene (speciﬁcally crtP) from an organism with oxygenic
photosynthesis was obtained from Synechococcus PCC7942 [48].
Algae
An interesting topic in the biosynthesis of carotenoids in algae
is the number of Psy gene types found in some species. There are
diatoms (Phaeodactylum tricornutum, Thalassiosira pseudonana),
red (Cyanidioschyzon merolae) and green algae (Volvox carteri, Chla-
mydomonas reinhardtii, Chlorella vulgaris) with only one class of
such gene [49,50]. Contrastingly, some other contain two classes
of Psy genes, like green algae from Ostreococcus sp. andMicromonas
sp. These and others contain two copies, which leads to hypothe-
size that there existed an old gene duplication event that resulted
in the occurrence of two classes of PSY in some algae. Studies in
other green algae like members of the Dunaliella sp. seem to indi-
cate that there may have also been more recent gene duplication
episodes. The presence of at least two classes of PSY enzymes in
algae may indicate that these can be regulated distinctly depend-
ing on factors like developmental stages or environmental stresses
for the adequate biosynthesis of carotenoids [31,50]. This is cer-
tainly important for the biotechnological production of carotenoids
for commercial purposes.
Plants
Genes encoding phytoene synthase have been identiﬁed in sev-
eral plants, like Arabidopsis, melon, Citrus sp., daffodil, marigold,
pepper, poplar, wheat, maize, rice, tomato and others. In rice, pop-
lar, tomato, wheat and maize there are two or more homolog
genes, whereas only one has been identiﬁed in Arabidopsis [51–
63]. The presence of two or more PSY enzymes seems to be impor-
tant in the control of carotenoid biosynthesis in different organs, at
different developmental stages or in response to environmental
stimuli, including stresses like salt and drought [27]. As an exam-
ple, two phytoene synthase genes (Psy1 and Psy2) are known to
exist in tomatoes, the expression of the former is increased in
the fruit during its ripening, whereas Psy1 expression predomi-
nates before [64,65]. On the other hand, maize PSY proteins can
be encoded by three paralogous genes. PSY1 is expressed in leaves
and the seed endosperm and confer to the latter its characteristic
yellow color. PSY2 is also expressed in leaves, whereas PSY3 is
expressed in roots. The expression of the latter has been shown
to be induced by stress [51,55,66,67]. The localization of PSY1 iso-
zymes is attracting much attention [68,69]. Interestingly, there is
evidence that allelic variation may affect the enzymatic activity
of PSY. As an example it has been shown in wheat that alternative
splicing resulted in the formation of four different transcripts, of
which only one proved to be functional [54].
Being a key regulatory enzyme in carotenoid biosynthesis, PSY
has been important for the modiﬁcation of the carotenoid levels
in crops by genetic engineering [70–74]. Psy from daffodil (along
with the bacterial phytoene desaturase CrtI) was introduced into
rice for the development of Golden Rice [75]. By replacing the daf-
fodil phytoene synthase gene with the maize Psy1 gene, Golden
Rice 2 (accumulating higher amounts of b-carotene) was obtained
[76]. At the transcriptional level, plant Psy genes have been shown
to respond to abscisic acid (ABA), temperature, photoperiod,
developmental events, high light, stresses (salt, drought) and
post-transcriptional feedback [27].
Phytoene desaturase (PDS) is the enzyme that introduces fur-
ther double bonds in phytoene to form f-carotene via phytoﬂuene.
Genes encoding this protein have been identiﬁed and obtained
from plants like Arabidopsis, tomato, pepper, maize, daffodil, soy-
bean, tobacco and some others [56,61,77–81].
PDS has been long known to be an important target site for
bleaching herbicides like norﬂurazon and ﬂuridone, among others.
Phytoene is accumulated at the expense of the typical colored
carotenoid as a result. This subject has been studied in detail cya-
nobacteria, algae and plants [82–87]. In a novel approach, norﬂur-
azon has been used in tomato cell cultures containing 14C-sucrose
in the medium to produce 14C-labeled phytoene to gain further
insight into the bioavailability and biological actions of this carot-
enoid [88].
Analysis
Separation
Thin-layer chromatography and open-column chromatography
Examples of separations and chromatographic parameters for
the analysis of phytoene and phytoﬂuene by classical chromato-
graphic techniques can be found in classical reference books for
carotenoid analysis. Due to their lack of color their bands cannot
be detected with the naked eye. Fluorescence can be used to
‘‘reveal’’ the presence of phytoﬂuene [11].
Liquid chromatography
The normal phase HPLC separation of isomers of both phytoene
and phytoﬂuene on an aluminum oxide column has been reported
[89]. Likewise the HPLC separation of up to 6 isomers of phytoﬂu-
ene on a calcium hydroxide column has been described [20].
In reverse phase C18 columns, this elution order is typically
observed: phytoﬂuene elutes before phytoene and both after other
food carotenes like lycopene, f-carotene, a-carotene and b-caro-
tene [11,90]. A rapid method allowing the isocratic separation of
phytoene and phytoﬂuene, along with other carotenoids, retinoids
and tocopherol in 12 min, using a Spheri-5-ODS column is well
described [91]. An ultra-high-pressure liquid chromatography
(UHPLC) method for their analysis along with 14 other carotenoids
have been recently proposed [92]. Likewise, a microextraction
method and a rapid liquid chromatography method have been
developed for the simultaneous determination of phytoene and
phytoﬂuene along with other dietary carotenoids, tocopherols
and chlorophylls [93]. These rapid methodologies are recommend-
able for screening purposes, as the separation of some carotenoid
isomers is not as effective as with other methodologies, mainly
using C30 columns.
In reverse phase C30 columns, this elution order is typically
observed: the major phytoene geometrical isomers elute before
the major phytoﬂuene isomers. The main b-carotene and lycopene
isomers elute later [22,94–96].
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It is interesting to note that coelutions of phytoﬂuene with
other non-carotenoid lipid compounds in animal samples (like
cholesteryl esters) have been reported [90].
Detection
UV–Vis spectroscopy
Typical spectra in a MeOH/MTBE-based mobile phase are
shown in Fig 3. Spectroscopic data of different geometrical isomers
of phytoene and phytoﬂuene have been reported elsewhere [22].
Fluorescence
As stated earlier phytoﬂuene is known to ﬂuoresce at around
510 nmwhen excited with near-UV light [13]. As an example, exci-
tation and emission wavelengths of 346 and 520 nm, respectively,
have been used [97]. By using this kind of detection a markedly
better sensitivity can be obtained. As an example, the ﬂuorimetric
detection of phytoﬂuene from serum samples as small as 200 ll
has been described. The objective of this study was to assess its
possible interference in the ﬂuorimetric detection of serum vita-
min A [98].
Mass spectrometry
Information about characteristics fragments obtained by elec-
tron impact ionization (EI) can be found in the Handbook of Carote-
noids [8] and elsewhere [99]. In the case of phytoene diagnostic
fragments atm/z 544 (molecular ion), 450, 339 and 69, among oth-
ers, are reported. In the case of phytoﬂuene diagnostic fragments at
m/z 542 (molecular ion), 448, 405, 337 and 69, among others, are
reported.
MS data obtained by HPLC–MS/MS using atmospheric pressure
chemical ionization (APCI) in positive mode are also well described
in the literature. Fragments atm/z 545, 489, 435, 395 and 339 were
detected as characteristic for phytoene, and at m/z 543, 461, 406
and 338 for phytoﬂuene [96,100].
Matrix-assisted laser desorption ionization coupled to time-of-
ﬂight mass spectrometry (MALDI/TOF-MS) has also been used for
the identiﬁcation of phytoene, phytoﬂuene and other plant carote-
noids. Very high mass accuracy as well as very high sensitivity
(picomolar) can be obtained by this approach. Masses accuracies
of 84 and 26 ppm were reported in their analysis in a tomato
mutant, speciﬁcally Tangella [101].
Nuclear magnetic resonance
1H and 13C NMR assignments of phytoene and phytoﬂuene are
reported in classical works [102,103]. A methodology for the rapid
NMR identiﬁcation of tomato carotenoids, including (15Z)-
phytoene, involving a CDCl3 extraction procedure and high-resolu-
tion multidimensional NMR techniques using a cryogenic probe is
described [104]. The identiﬁcation of both carotenoids in tomato
juice by 1H-NMR coupled to HPLC has also been reported [105].
Occurrence in foods, dietary intake and possible
epidemiological implications
Occurrence in foods
The content of secondary metabolites like carotenoids in foods
are dependent on factors of different nature like genetic,
agronomic or technological ones [106]. Very important content dif-
ferences (ca. 4-fold in the case of phytoﬂuene and ca. 6-fold in the
case of phytoene) even in tomatoes of the same variety cultivated
under the same conditions have been observed [21]. The meaning-
ful comparison of phytoene and phytoﬂuene levels between differ-
ent foods is therefore very complicated. In order to classify their
content in common foods we have compiled data reported in the
literature and determine, whenever possible, their average content
and range in different samples. The criteria proposed by Britton
and Khachik [107] to categorize the carotenoid levels in food
sources as low (those containing between 0 and 0.1 mg/100 g of
fresh weight), moderate (between 0.1 and 0.5 mg/100 g of fresh
weight), high (0.5–2 mg/100 g of fresh weight) or very high (more
than 2 mg/100 g of fresh weight), was followed. The results are
summarized in Table 1. As it can be observed, large quantitative
differences within the same food are common. In virtually all the
cases, the phytoene content was higher relative to phytoﬂuene.
High or very high contents of them can be found for instance in
apricot, carrots, tomatoes and derivatives, red grapefruits, water-
melon and some peppers (Table 1).
Apart from these foods, the presence of colorless carotenoids
has been described in palm oil [108,109], gac [110], yellow passion
fruit [99], loquats [95], citrus mutants [111–114], buriti, mamey,
marimari, and physalis [94], among others.
Dietary intake
The dietary intake of phytoene and phytoﬂuene has been lar-
gely ignored, very probably because of their absence in the classi-
cal carotenoid databases. To the best of our understanding, the
only existing study that consider it is the one by Biehler et al.
[115]. The Luxembourgish daily intakes per person were estimated
to be 2.0 mg in the case of phytoene and 0.7 mg in the case of phy-
toﬂuene. Interestingly the estimated daily intake of lycopene was
lower (1.8 mg) than that of phytoene. The percentage intake of
Fig. 3. Typical UV spectra of phytoene (in red, absorption maximum at 285 nm) and phytoﬂuene (in blue, absorption maxima at 331, 347 and 365 nm) in a MeOH/MTBE-
based mobile phase.
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Table 1
Compilation of contents (mg/kg fresh weight or mg/L) on phytoene and phytoﬂuene. They are categorized as low (L), moderate (M), high (H) and very high (VH) according to the
criteria proposed by Britton and Khachik [107].
Source Scientiﬁc name Phytoene Phytoﬂuene Refs.
Mean (range)
Categorization
Apricot Prunus armeniaca 2.76 (0.06–7.1) 0.95 (0.02–2.38) [115,152,156]
VH (L-VH) H (L-VH)
Apricot (white) Prunus armeniaca 1.26 (0.66–2.19) 0.89 (0.66–2.19) [151]
H (H-VH) H (H-VH)
Apricot (yellow) Prunus armeniaca 1.34 (0.65–2.65) 0.97 (0.45–1.72) [151]
H (H-VH) H (M-H)
Apricot (light orange) Prunus armeniaca 2.26 (1.54–3.29) 1.44 (0.91–2.02) [151]
H (H-VH) H (H-VH)
Apricot (orange) Prunus armeniaca 1.68 (1.23–4.97) 2.78 (0.09–3.31) [151]
H (H-VH) VH (L-VH)
Apricot (canned) Prunus armeniaca 0.10 0.06 [152]
M L
Apricot (dried) Prunus armeniaca 0.24 0.14 [152]
M M
Avocado Persea americana 0.03 – [156]
L
Banana Musa paradisiaca 0.03 – [115]
L
Caja (juice) Spondias lutea 0.04 – [153]
L
Caja (pulp) Spondias lutea 0.04 (0.02–0.05) – [153]
L
Cantaloupe Cucumis melo 0.04 0.04 [152]
L L
Carrot Daucus carota 1.34 0.57 [115]
H H
Carrot (juice) Daucus carota 1.23 0.55 [115]
H H
Clementine Citrus clementina 0.07 0.07 [156]
L L
Clementine (juice) Citrus clementina 0.04 0.09 [150]
L L
Grapefruit Citrus paradisi 0.07 0.06 [156]
L L
Grapefruit (red) Citrus paradisi 1.25 (0.25–5.13) 0.51 (0.17–1.69) [154]
H (M-VH) H (M-H)
Grapefruit (pink) Citrus paradisi 0.32 (0.01–0.62) 0.11 (0.01–0.21) [115,152]
M (L-H) M (L-M)
Grapefruit (juice) Citrus paradisi 0.21 0.07 [115]
M L
Lemon Citrus x limon 0.01 – [156]
L
Mandarin (juice) Citrus reticulata 0.15 (0.12–0.19) 0.28 (0.23–0.34) [150]
M M
Minestrone soup 0.28 0.17 [155]
M M
Melon Cucumis melo 0.25 – [115]
M
Nectarine Prunus persica 0.40 0.12 [156]
M M
Autumn olive Elaeagnus umbellata 0.41 (0.00–0.65) 0.11 (0.07–0.17) [150]
M (L-H) M (L-M)
Orange (juice) Citrus sinensis 0.08 (0.05–0.10) 0.07 (0.05–0.10) [150]
L L
Orange Citrus sinensis 0.23 (0.05–0.56) 0.11 (0.04–0.18) [115,156,148]
M (L-H) M (L-M)
Papaya Carica papaya 0.25 0.26 [156]
M M
Peach Prunus persica 0.11 (0.01–0.18) 0.047 (0.002–0.07) [115,152,156]
M (L-M) L
Peach (canned) Prunus persica 0.01 – [152]
L
Peach (dried) Prunus persica 0.01 0.03 [152]
L L
Pepper (orange) Capsicum annuum 1.01 0.31 [115]
H M
Pepper (red) Capsicum annuum 1.69 0.51 [115]
H H
Pepper (yellow) Capsicum annuum 0.42 0.22 [115]
M M
(continued on next page)
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phytoene + phytoﬂuene was 16% (2.7 mg) of total carotenoid
intake [115].
Possible epidemiological implications
Phytoene and phytoﬂuene are found together with lycopene in
tomato products and other lycopene-containing foods like water-
melons, red grapefruits, etc., although their individual concentra-
tions are typically lower. However, their distribution is much
broader and they occur in products very frequently consumed like
oranges and carrots, among others, as it can be observed in Table 1
and the study by Biehler et al. [115]. In this sense it would not be
surprising to ﬁnd higher dietary intakes of phytoene or phyto-
ene + phytoﬂuene relative to lycopene in other countries. This is
of great importance from an epidemiological point of view and
raises the question of whether the colorless carotenoids were
‘‘undercover’’ in the studies ﬁnding associations between the con-
sumption of tomatoes and health beneﬁts. The effects of tomato
product supplementation on biomarkers of oxidative stress and
carcinogenesis in human clinical trials was reviewed by Basu and
Imrhan [116]. One of the main conclusions of their study was that
the consumption of tomato products leads to health beneﬁts,
although those should be related to the occurrence of lycopene
together with several compounds naturally present in tomatoes.
According to this review, there is limited in vivo evidence on the
health beneﬁts of lycopene on its own as the majority of the clinical
trials evaluated suggest the existence of synergistic effects involv-
ing lycopene and other compounds in reducing the levels of the bio-
markers evaluated [116]. On the other hand, a recently published
study concludes that there is evidence for an inverse association
between lycopene intake and risk of cardiovascular disease, albeit
more research is required to demonstrate if lycopene or other
tomato compounds are responsible for such association [117]. In
this sense it is important to note that, aside from carotenoids, toma-
toes also contain other nutritionally relevant compounds like phe-
nolic compounds and ascorbic acid, among others, and that
synergistic effects among different species can occur [118,119].
Bioavailability
Laboratory animals
Rats
Phytoene and phytoﬂuene were found to be bioavailable in
Sprague–Dawley rats fed a dry powder (1 g/kg diet) from a strain
of the microalga Dunaliella bardawil. The dry material contained
phytoene at 2% and phytoﬂuene at 0.1%. The largest accumulation
of phytoene was found in liver, followed by adrenals. The levels in
other tissues like brain, heart, lung, kidney and spleen were consid-
erably lower [120].
In order to gain insight into the tissue distribution of phytoene,
phytoﬂuene and lycopene, male Fisher 344 rats were fed a diet
containing 10% of tomato powder with similar concentrations of
the three carotenoids (0.015, 0.012, and 0.011 g/kg diet, respec-
tively). At the end of the study the major plasma carotenoid was
phytoene, followed by phytoﬂuene. The hepatic phytoﬂuene con-
centration was found to be ca. 1.5-fold higher than that of the other
two. Contrastingly, phytoene levels were the lowest and lycopene
levels the highest in the prostate lobes and seminal vesicles. Differ-
ent accumulation patterns were also found in other tissues. The
authors concluded that the relative distribution of the three carote-
noids was distinct in liver and androgen-sensitive tissues and that
phytoene could be absorbed more readily than lycopene [121].
Another study evaluated the effect of tomato powders in the
accumulation of their major carotenoids in male Copenhagen rats.
It was observed that different carotenoid levels in the powders
resulted in distinct hepatic accumulations. Thus, the use of a
tomato powder with over twice the amount of lycopene relative
to the standard powder resulted in signiﬁcant higher lycopene
accumulation and signiﬁcantly lower phytoene and phytoﬂuene
accumulation relative to the standard. The animals supplementa-
tion with a third type of powder with a higher total carotenoid con-
tent with signiﬁcantly more phytoene and phytoﬂuene but not
enhanced lycopene accumulated signiﬁcantly more hepatic color-
less carotenoids but the same quantity of lycopene relative to the
Table 1 (continued)
Source Scientiﬁc name Phytoene Phytoﬂuene Refs.
Mean (range)
Categorization
Spaguetti sauce 2.77 0.16 [155]
VH M
Tomato Solanum lycopersicum 1.0 (0.6–1.38) 0.45 (0.40–0.51) [115,156,152]
H M (M-H)
Tomato (whole canned) Solanum lycopersicum 1.86 0.82 [155]
H H
Tomato (paste) Solanum lycopersicum 4.94 (1.52–8.36) 2.85 (2.08–3.63) [155,152]
VH VH
Tomato (juice) Solanum lycopersicum 1.77 (1.64–1.90) 0.63 (0.44–0.83) [115,155]
H H (M-H)
Tomato (ketchup) 3.44 (3.39–3.49) 1.29 (1.03–1.54) [115,155]
VH H
Tomato (soup) Solanum lycopersicum 1.72 0.72 ± 0.18 [155]
H H
Tomato (sauce) Solanum lycopersicum 2.95 1.27 [155]
VH H
Tomato (puree) Solanum lycopersicum 2.40 1.08 [155]
VH H
Vegetable beef soup 0.35 0.19 [155]
M M
Vegetarian soup 0.60 0.31 [155]
H M
Vegetable juice 1.71 0.69 [155]
H H
Watermelon Citrullus lanatus 1.17 0.44 [115]
H M
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standard powder-fed rats. The analysis of the results seem to indi-
cate that there may be interaction between the three carotenoids
in the processes related to their bioavailability [122].
The effect of supplementing the diet of male Sprague–Dawley
with a tomato extract on high-fat-diet related liver inﬂammation,
lipid proﬁles and carcinogenesis has been recently studied. The
animals were fed either a control diet (35% fat, CD) or a high fat
diet (71% fat, HFD) with or without the tomato supplementation.
The tomato extract contained lycopene, phytoene and phytoﬂuene
in a ratio 1.0:0.6:0.3. Up to 5 different isomers of phytoﬂuene were
detected in the extract. The plasma levels of lycopene were the
lowest and those of phytoene the highest in both CD and HFD
groups. More speciﬁcally, the plasma levels of phytoene and phy-
toﬂuene were ca. 7-fold and 3.5-fold greater respectively, than
those of lycopene in the animals receiving the CD plus the tomato
supplementation. In the case of the group receiving HFD and
tomato supplementation the concentrations of PT and PTF were
even higher relative to those of lycopene (ca. 34-fold and 9-fold,
respectively). The hepatic levels of lycopene were the lowest and
those of PT the highest in the two groups. Interestingly the levels
of hepatic lycopene in the rats receiving the HFD plus tomato were
signiﬁcantly higher relative to the group receiving CD plus tomato.
It was concluded that there are differences in the factors governing
the bioavailability of the three carotenoids and that the effect of
differences in their chemical structure, mainly geometrical isomer-
ism and number of conjugated double bonds, needs more research
[123].
Ferrets
Most of the studies dealing with the bioavailability of phytoene
and phytoﬂuene in laboratory animals were carried out in rats.
However, ferrets are known to absorb carotenoids more efﬁciently.
Both phytoene ((15Z)- and all-E-phytoene) and phytoﬂuene (up to
5 isomers), along with several geometrical isomers of both b-caro-
tene and lycopene have been reported to accumulate in the lungs
of male ferrets receiving a diet supplemented with a tomato
extract [22].
Mongolian gerbils
A recent study has been carried out in order to gain insight into
the different absorption and accumulation of lycopene and phyto-
tene. In brief, Mongolian gerbils (n = 56) were fed a diet containing
tomato powder for 26 days. Subsequently, the animals were given
either a single cottonseed oil vehicle dose or phytoene or lycopene
in cotton oil. Lycopene was found to be predominant in liver,
spleen, testes and prostate-seminal vesicle in the animals receiving
just the vehicle. Phytoene was the major carotenoid in serum and
adipose tissue, whereas phytoﬂuene was predominant in adrenals
and lungs. The dosing with phytoene and lycopene indicated that
the former was more bioavailable and had a slower clearance than
the latter. To gain further insight into differences in the accumula-
tion of both carotenoids, labeled carotenoids ((14)C-phytoene or
(14)C-lycopene) was supplied to animals fed tomato powder.
Interestingly, it was observed that almost all extra-hepatic tissue
accumulated more radioactivity after labeled-phytoene than
labeled-lycopene dosing. Altogether, the data from this interesting
study conﬁrmed that there are important differences between
these two carotenoids in bioavailability, tissue accumulation and
clearance [124].
Humans
Presence in human biological ﬂuids
Interestingly, a study showed that the plasma levels of phytoﬂ-
uene, as well as of lycopene, lutein/zeaxanthin and vitamin E were
similar in both smoking and non-smoking Scottish males, while
those of the provitamin A carotenoids (a-carotene, b-carotene
and b-cryptoxanthin) and vitamin C were lower in the ﬁrst group
[125].
Both phytoene and phytoﬂuene were found to be present in the
serum and breast milk of lactating women (n = 3), the contents
being lower in the latter. The reported levels of phytoﬂuene were
higher in both biological ﬂuids, between 7.8 and 13.9 lg/dL in
serum and 0.4 and 1.4 lg/dL in milk. In the case of phytoene the
serum levels ranged between 1.9 and 3.3 lg/dL and those found
in milk where 0.1 lg/dL [90].
In a thorough randomized crossover design study, 9 women and
7 men were administered lycopene-rich tomato juice (476 mL/day;
74.9 mg of lycopene, 5.11 mg of phytoﬂuene and 5.76 mg of phyto-
ene/day), oleoresin soft-gel capsules (4 capsules/day; 75.4 mg of
lycopene, 4.91 mg of phytoﬂuene and 4.40 mg of phytoene/day),
lycopene beadlets (15 capsules/day; 70.2 mg of lycopene,
3.67 mg of phytoﬂuene and 2.46 mg of phytoene/day) or placebo
for 4 weeks each while consuming self-selected diets. The reported
baseline plasma levels ranged between 0.54 and 0.60 lM in the
case of lycopene, 0.27 and 0.30 lM in the case of phytoﬂuene
and 0.10 and 0.11 lM in the case of phytoene. Averaging the four
treatments, it was found that the highest proportion of the three
carotenes (ranging from 65% in phytoﬂuene to 76% in phytoene
and lycopene) was found in LDL. This agreed well with the
accepted observation that carotenes are mainly found in those
lipoproteins. Interestingly, the authors observed subtle differences
in the distribution pattern of phytoﬂuene and phytoene among
lipoproteins compared to the other major circulating carotenes
(lycopene, a-carotene and b-carotene). Thus their relative contents
were found to be higher in VLDLs and lower in both LDLs and HDLs.
The changes relative from baseline ranged between 0.16 (pla-
cebo) and 0.24 lM (oleoresin) in the case of lycopene, 0.08 (pla-
cebo) and 0.45 lM (juice) in the case of phytoﬂuene and 0.02
(placebo) and 0.19 lM (juice) in the case of phytoene. In sum it
was concluded that the plasma concentration of the three com-
pounds were signiﬁcantly increased with the three carotenoid
sources tested [126]. In relation to this study it is to be noted that
the daily intake of the three carotenoids was higher than those
achievable by a ‘‘normal diet’’, specially true in the case of lyco-
pene, as it can be noticed by comparing these data with the
reported by Biehler et al. [115].
In a study performed to assess changes in the plasma levels of
carotenoids and other compounds, 23 male healthy individuals
were subjected to a 2-week carotenoid depletion period and then
supplemented with a series of carotenoid rich products (330 mL
tomato juice for 2 weeks, then 330 mL carrot juice for 2 weeks
and then 10 g spinach powder for 2 weeks). During the study the
individuals maintained mostly their usual diets, although they
were asked to avoid a series of carotenoid-rich products. The aver-
age levels of phytoﬂuene were 0.14 nmol/mL and 0.12 at the begin-
ning and the end of the washout period, respectively. In the case of
phytoene, such mean levels were 0.14 and 0.09, which could indi-
cate that the depletion of phytoene is faster under the conditions
tested. At the end of the tomato and carrot supplementation peri-
ods (both sources containing the two carotenoids) the plasma lev-
els peaked, reaching concentrations of 0.44 nmol/mL for phytoene
and 0.55 nmol/mL for phytoﬂuene. After the 2 weeks of supple-
mentation with spinach (which is not a good source of phytoene
and phytoﬂuene) their plasma level decreased noticeably (0.29
and 0.26 nmol/mL for phytoene and phytoﬂuene, respectively)
[127].
The effect of watermelon consumption in the plasma levels of
lycopene and other carotenoids was studied by Edwards et al.
[128]. The plasma levels of carotenoids in 23 volunteers following
supplementation with watermelon juice in a 19-week crossover
study was studied. The volunteers were subjected to three 3-week
A.J. Meléndez-Martínez et al. / Archives of Biochemistry and Biophysics 572 (2015) 188–200 195
supplementation periods preceded by lycopene depletion periods
ranging from 2 to 4 weeks. All consumed a watermelon juice pro-
viding 20.1 mg/day lycopene (W-20 treatment). After a washout
period, the volunteers were provided either watermelon supplying
40.2 mg/day lycopene (W-40 treatment) or tomato juice supplying
18.4 mg/day lycopene (T-20 treatment). The authors observed that
both phytoﬂuene and phytoene levels doubled after the T-20
tomato treatment. Phytoene was found to be bioavailable from
the watermelon juice, but particularly from the tomato juice. The
plasma levels of phytoﬂuene were observed to increase only for
the T-20 supplementation, not for the watermelon juices treat-
ments [128].
The bioavailability of lycopene and phytoﬂuene from a tomato
paste and a food formulation where the carotenoids were
entrapped in whey proteins (‘‘lactolycopene’’) was compared in
36 volunteers (13 men and 23 women) by Richelle et al. [129].
The individuals were allocated in random to one of three treatment
groups (25 mg/day lycopene and 1.6 mg/day phytoﬂuene from
tomato paste, 25 mg/day lycopene and 1.98 mg/day phytoﬂuene
from lactolycopene or placebo of whey proteins). They followed
the treatments for 8 weeks while eating their self-selected diets
with restriction of lycopene-rich foods. Previously they were sub-
jected to a 3-week lycopene washout period. The daily supplemen-
tation resulted in signiﬁcant increases in the plasma levels of
phytoﬂuene after the 8-week interventions. The increase was
lower with lactolycopene than with tomato paste (0.23 and
0.33 lmol/L increases, respectively) [129].
In another interesting study 36 healthy volunteers were ran-
domly allocated to three groups (n = 12), who ingested either syn-
thetic lycopene in beadlets (two hard shell capsules per day;
5.1 mg/capsule), a commercial tomato extract in soft gel capsules
(2 capsules per day; 4.9 mg lycopene, 0.4 mg phytoﬂuene, 0.5 mg
phytoene, and 0.2 mg b-carotene/capsule) or a commercial
tomato-based drink (250 mL two times per day; 4.1 mg lycopene,
1.6 mg [130] phytoﬂuene, 2.3 mg phytoene, and 0.2 mg b-caro-
tene/250 mL). Different isomers of phytoene and phytoﬂuene were
detected in the two latter products. The supplementation lasted
12 weeks. The basal plasma levels of the carotenoids in the three
groups ranged between 0.28 and 0.37 nmol/mL (lycopene), 0.27
and 0.44 nmol/mL (phytoﬂuene) and 0.06 and 0.07 nmol/mL (phy-
toene). At the end of the study the lycopene levels ranged between
0.55 and 0.88 nmol/mL, The phytoﬂuene plasma levels increased
from 0.44 nmol/mL at t = 0 to 0.94 nmol/mL in the tomato extract
group and from 0.27 to 0.87 nmol/mL in the tomato drink one.
The effect of the interventions in the serum phytoene levels were
less pronounced but still noticeable (ca. 2-fold) [130].
Increases in the plasma levels of phytoene, phytoﬂuene and
lycopene upon supplementation have also been reported in
another studies, in which increases in their levels in lymphocytes
were also observed [131].
Presence in human tissues
The information about the presence of phytoene and phytoﬂu-
ene in human tissues is very limited. Phytoene and phytoﬂuene
have been reported to accumulate in liver, lung, breast, cervix,
prostate, colon and skin in the range of ng/g in samples from very
few individuals (n = 3–5). The patterns of deposition in such tissues
was not consistent. Higher levels of phytoﬂuene over phytoene
were found in all except lung and skin (reviewed in [132]).
The production and use of isotopically labeled colorless carote-
noids [38,133,134] is expected to shed light in the factors involved
in their bioavailability, many of which remain obscure. They are
specially useful to study the fate of a dose of the compound in indi-
viduals already containing an endogenous pool of it, which is the
common situation as carotenoids are part of any normal diet and
it is difﬁcult to deplete them with the washout periods tradition-
ally used in interventions.
Possible biological actions
There are studies of different nature (in vitro, using laboratory
animals or in humans) that indicate that the colorless carotenoids
phytoene and phytoﬂuene may be involved, in their own or in con-
junction with other food constituents, in biological actions that
could provide health beneﬁts. At this point it is important to con-
sider that it is necessary to distinguish between physiological and
pharmacological levels in order to better interpret the results
reported in the studies. The concentrations reported in the previ-
ous sections (‘‘Presence in human biological ﬂuids’’ and ‘‘Presence
in human tissues’’) can be very useful for this purpose. An excellent
review on nutritional aspects related to phytoene and phytoﬂuene
including potential biological effects has been recently published
[157].
Cancer
Skin
One of the ﬁrst reports on the possible antitumor activity of
carotenoids in general was probably the published study by Mat-
thews-Roth [135]. In this, the administration of phytoene was
observed to delay the skin tumors appearance and reduce their
number in mice that were induced the tumors with UV-B light.
Prostate
The ﬁst report on the possible beneﬁcial effect of colorless
carotenoids in prostate cancer is probably the published study by
Kotake-Nara et al. [136]. In such investigation the effect of 15
carotenoids, including phytoene and phytoﬂuene, on the viability
of PC-3, DU 145 and LNCaP human prostate cancer cell lines was
assessed. Phytoﬂuene, but not phytoene, was shown to reduce
the viability of cancer cells when supplemented at 20 lM in the
medium for 72 h [136].
Very interestingly, in a study in which a prostate cancer model
was used, a signiﬁcantly lower risk of death from that malignancy
was observed in rats fed tomato powder (containing PT and PTF
and other compounds in addition to lycopene) but little effect
was observed in the rats fed pure LYC. The authors concluded that
the intake of tomato powder but not only lycopene inhibited pros-
tate carcinogenesis and that there were other compounds in
tomato that modiﬁed the carcinogenesis [137].
Phytoﬂuene and lycopene on their own or as part of tomato
may have a beneﬁcial role in prostate cancer by reducing serum
testosterone, as demonstrated in a study using F344 rats [138]. It
has been observed that castration or lower androgen status
resulted in higher levels of both carotenoids in plasma, prostate
and seminal vesicles of the rats receiving doses of the carotenoids.
Interestingly, these responses were not consistent when tomato
powder was administered. The authors hypothesized that, since
oxidative stress events associated to the metabolism of androgens
could lead to the consumption of carotenoids, alterations in such
metabolism could have an impact in their levels [138].
Leukemia
The effect of both acyclic carotenes (phytoene, phytoﬂuene, f-
carotene and lycopene) and some oxidation products of them in
the proliferation of human promyelocytic leukemia cells was stud-
ied using in vitro HL-60 cell line cultures [139]. The addition of f-
carotene and phytoﬂuene at 10 lM into the culture medium led
to inhibition of cell growth relative to the control, the effect being
markedly higher in the case of the former (ca. 4% cell density of the
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control vs ca. 23 in the case of phytoﬂuene). Interestingly, they
were not detected in the cells indicating that they were highly
unstable under the conditions tested. An interesting ﬁnding of this
study was that oxidation mixtures of each tested carotenoid (con-
taining also some residual intact carotenoid) inhibited the growth
of the cells. The inhibition was greater compared to the obtained
when the respective parent carotenoids were tested. As an exam-
ple, the oxidation mixture of phytoﬂuene at 6 lM inhibited cell
growth to ca. 8%, while pure phytoﬂuene at the same concentration
inhibited it to a much lower extent (ca. 68%). It is to be noted that
the effect of mixtures of oxidation products of phytoene was not
evaluated [139].
Breast and endometrial cancer
The effect of phytoene, phytoﬂuene and other carotenoids in the
inhibition of cell proliferation and estrogen transcriptional activity
induced by estrogens (17b-estradiol and soy phytoestrogens) was
studied by Hirsch et al. [140]. To this end, cell lines of breast
(MCF-7 and T47D) and endometrial (ECC-1) hormone-dependent
cancer cells were treated with increasing amounts of either 17b-
estradiol or the soy phytoestrogen genistein in presence or absence
of the carotenoids. Both phytoene and phytoﬂuene at a concentra-
tion of 4–6 lM in the medium were shown to inhibit the prolifer-
ation of the cells induced by the tested estrogens. Additionally, all
the carotenoids evaluated inhibited the estrogen-induced transac-
tivation of the estrogen response element (ERE) [140].
An ingenious approach to study the effects of carotenoids in
events related to carcinogenesis is to transfect the animal cells
with carotenogenic genes so that the carotenoids are formed in
the cells. As an example, a bacterial phytoene synthase gene was
introduced in mouse embryonic ﬁbroblasts (NIH3T3). The produc-
tion of phytoene led by the transgenic cells led to protection
against oxidative stress (assessed by measuring phospholipid per-
oxidation induced by oxidative stress) and malignant transforma-
tion. The authors stated that the term ‘‘bio-chemoprevention’’
(‘‘biotechnology-assisted method for cancer chemoprevention’’)
may be applicable in this context as the transgenic cells acquired
resistance against carcinogenesis [141].
Oxidation
The colorless carotenoids might protect LDL from oxidation
according to the results of an in vitro study in which oxidized
human LDLs were treated with phytoene and phytoﬂuene from
the microalgae D. bardawil. The protection of these particles from
oxidation is important as LDL oxidation is thought to be a key
event in the pathogenesis of cardiovascular disease [142].
The effect of phytoene, phytoﬂuene and lycopene on the antiox-
idant response element (ARE) and nuclear factor E2-related factor
(Nrf2) was studied by Ben-Dor et al. [143]. Both ARE and Nrf2 are
involved in the control of the expression of phase II enzymes, some
of which like NAD(P)H:quinone oxidoreductase (NQO1) and c-
glutamylcysteine synthetase (GCS) have been shown to be induc-
ible. These phase II enzymes are beneﬁcial as they can detoxify
harmful compounds by converting them to hydrophilic derivatives
that can be readily excreted. A mixture of phytoene and phytoﬂu-
ene (70:30) (4–6 lM) was shown to transactivate ARE Sequences
of GCS and NQO1genes in transfected MCF-7 and HepG2 cell lines,
although the effect was noticeably less pronounced as that caused
by lycopene (2–4 lM). It was also observed that both the mixture
of colorless carotenoids and lycopene decreased the intracellular
levels of reactive oxygen species at comparable levels [143].
The effect of the intake of a tomato drink providing lycopene,
phytoene and phytoﬂuene in lymphocytes subjected to oxidative
stress has been evaluated [131]. The daily supplementation with
250 mL of the drink (which provided approximately 6 mg lyco-
pene, 4 mg phytoene, 3 mg phytoﬂuene, 1 mg b-carotene and
1.8 mg a-tocopherol) led to signiﬁcant increases in the plasma lev-
els of the carotenoids (speciﬁcally 1.6-fold for phytoﬂuene and ca.
2-fold for phytoene) and their content in lymphocytes (1.8-fold
higher in the case of phytoﬂuene and 2.6-fold higher in the case
of phytoene). The consumption of the drink was also shown to sig-
niﬁcantly decrease the DNA damage (assessed by the comet assay)
of lymphocytes under oxidative stress, suggesting that a realistic
intake of carotenoids from tomato products can protect the cell
against oxidation [131].
Light-induced skin damage
The protective effects of colorless carotenoids against light
caused lesions in the skin were already postulated 30 years ago.
More speciﬁcally, a study showed that large doses of phytoene
injected to guinea pigs for 2 weeks could somewhat protect the
animals from UV-induced erythema in comparison to those receiv-
ing placebo [144].
Carotenoids, including phytoene and phytoﬂuene, are known to
accumulate in human skin (in the range of nmol/g wet tissue),
preferably in the forehead, palm of the hand and dorsal skin. In
fact, it is well known that the intake of large quantities of carote-
noids can produce carotenodermia, a phenomenon characterized
by changes in the skin color to yellow or yellow-orange. Excessive
exposure to light can result in disorders of different magnitude,
from erythemas to cancer. Depending on the wavelength range
the light reaches different locations of the skin. Thus, UVA (320–
400 nm) reaches the entire dermis but UVB (280–320 nm) reaches
the epidermis in the main. As an example, excessive UVB radiation
can cause erythemas (also known as sunburn). Other skin disorders
caused by light, like photooxidation are mediated by reactive oxy-
gen species and can lead to premature skin aging or cancer, among
other disorders (reviewed in [145]). As stated earlier, phytoene and
phytoﬂuene are rarities among carotenoids because they absorb
UV light. In this sense it is reasonable to expect that they could
contribute to photoprotection by absorbing such damaging light.
In this sense, there is evidence that they could protect from UV-
light-induced erythema [130]. In this study, volunteers were sup-
plemented with synthetic lycopene, a tomato extract or a
tomato-based drink (all of them supplying approximately about
10 mg lycopene/day) for 12 weeks. Such intervention led to signif-
icant increases in plasma and skin carotenoid levels and to preven-
tion of erythema-induced formation in all groups. Interestingly, the
protective effect was more pronounced when the tomato based
products were used, suggesting that phytoﬂuene and phytoene
may have contributed to the effect [130].
Although the dietary protection attributable to the intake of
carotenoids and other food constituents could not be comparable
to that provided by sunscreens, the enhancement of basal protec-
tion can be important for the long-term defense from skin disor-
ders caused by light [146].
The effects of ubiquinone (coenzyme Q10) and colorless carote-
noids on the inﬂammation of human dermal ﬁbroblasts subjected
to UV light have been investigated in order to assess possible syn-
ergistic effects [147]. To this end dermal ﬁbroblast cells from
human neonatal foreskin were cultured in vitro, subjected to either
UV light or interleukin 1 (IL-1) and subsequently incubated with
either the coenzyme, phytoene plus phytoﬂuene (ﬁnal concentra-
tion of 15 lg/mL) or combinations of the coenzyme and the carote-
noids. The exposure to UV radiation or IL-1 increased the
production of several inﬂammatory mediators by the cells. The
combination or colorless carotenoids and the coenzyme was
shown to enhance the inﬂammatory response. Interestingly, phy-
toene and phytoﬂuene seemed to protect coenzyme Q10 from oxi-
dation by hypochlorite [147].
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Lipid metabolism
The effects of supplementing tomato extract (TE) against
high-fat-diet related hepatic inﬂammation and lipid proﬁles and
carcinogenesis has been recently investigated in rats. Four groups
of rats were treated with a liver carcinogen and then provided a
control diet (35% fat, CD) or high fat diet (71% fat, HFD) in the pres-
ence or absence of a tomato extract (50 mg/kg body weight per
day) during 6 weeks. According to the manufacturer, the tomato
extract contained approximately 6% LYC, 1% PT and 1% PTF. The
intake of the tomato extract resulted in higher phytoene and phy-
toﬂuene plasma. More especiﬁcally, The plasma levels of PT were
approximately 7-fold higher relative to lycopene in the rats receiv-
ing CD + TE and 34-fold higher in the ones receiving HFD + TE. The
plasma levels of PTF were 3.5-fold and 9-fold higher relative to LYC
in CD + TE and HFD + TE rats, respectively. Independently of the
amount of fat in the diet the phytoene hepatic levels were the
highest and the lycopene levels the lowest. This was associated
to a decrease of plasma total cholesterol in tomato supplemented
CD and HFD animals. Contrastingly, the supplementation with
the extract resulted in a signiﬁcant increase in the hepatic levels
of all the lipids evaluated (total cholesterol, triglycerides and free
fatty acids) except those of free fatty acids in animals on CD.
Changes in the expression of genes encoding proteins involved in
lipid metabolism, like acetyl-CoA carboxylase (ACC-1), diacylglyc-
erol acyltransferase (DGAT), carnitine palmitoyltransferase (CPT-
1), the peroxisome proliferator-activated receptor gamma (PPARc)
and the sterol-regulatory element binding protein (SREBP-1), were
observed. The tomato supplementation in CD and HFD-fed animals
also led to signiﬁcant increases in the mRNA levels of cluster of dif-
ferentiation 36 (CD36), a type of class B scavenger receptor, which
intervenes in the uptake of plasma FFA by the liver. On the other
hand, the tomato supplementation signiﬁcantly decreased the
multiplicity of inﬂammatory and altered hepatic foci in the liver
of HFD-fed rats [123]. Contrastingly, no changes in inﬂammatory
markers were observed in a study referred to before where gerbils
were fed tomato powder plus lycopene or phytoene [124].
The peroxisome proliferator-activated receptors (PPARs) belong
to the nuclear receptor superfamily and play key roles in lipid
metabolism, insulin resistance, inﬂammation and other processes
[148]. The capacity of tomato fruit extracts and tomato compo-
nents to activate PPARc has been recently evaluated by using a
reporter cell line [149]. Up to thirty tomato compounds were
assayed, including seven carotenoids. While phytoene was found
to be inactive, phytoﬂuene at 1 lM and 10 lM was observed to
activate the receptor at comparable levels in comparison to lyco-
pene [149].
In conclusion, it can be stated that phytoene and phytoﬂuene
are common dietary carotenoids. They are present together with
lycopene in tomatoes and derivatives and other foods. Besides they
are also present in widely consumed plant foods like oranges, man-
darins and carrots, among others. In fact, their intake may be
higher than that of lycopene. Interestingly, they are consistently
found in human plasma, milk and tissues and there are evidences
of different nature associating them with biological actions,
although causality needs to be established. In this regard, further
studies on them from different standpoints are encouraged.
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